impact factor, citescore
logo
In press
In Press
Recent issue
Recent issue
Recent Supplement
Recent supplement
archives
Archives
articles free
Free to view
Search
Search
 

Full Papers

 

Suicidal ideation among patients with Behçet's syndrome

1, 2, 3, 4

 

  1. Behçet’s Syndrome Research Centre, Istanbul University, Istanbul, Turkey.
  2. Behçet’s Syndrome Research Centre, Istanbul University, Istanbul, Turkey.
  3. Behçet’s Syndrome Research Centre, Istanbul University, Istanbul, Turkey.
  4. Behçet’s Syndrome Research Centre, Istanbul University, Istanbul, Turkey. vhamuryudan@yahoo.com

CER7878
2015 Vol.33, N°6 ,Suppl.94
PI 0030, PF 0035
Full Papers

Free to view
(click on article PDF icon to read the article)

PMID: 25797433 [PubMed]

Received: 31/08/2014
Accepted : 13/01/2015
In Press: 23/03/2015
Published: 04/11/2015

Abstract

OBJECTIVES:
To evaluate the frequency of suicidal ideation among Behçet’s syndrome (BS) patients compared to healthy and diseased controls and to delineate possible factors predicting an increase in suicidal ideation.
METHODS:
We included consecutive BS patients attending our outpatient clinic, patients with ankylosing spondylitis (AS) and healthy hospital staff as controls. Suicidal ideation was assessed by a standard questionnaire. Linear regression was used to identify the factors associated with suicidal ideation, such as demographic and clinical features, drugs, disease activity assessed using the Behçet’s disease current activity form (BDCAF) for BS patients and BASDAI for AS patients, Behçet’s disease quality of life (BDQoL) and Beck depression inventory (BDI) score.
RESULTS:
We surveyed 303 BS patients, 52 AS patients and 106 healthy controls. Suicidal thoughts, as reflected by a positive response to the first three items of the questionnaire, were higher among BS patients with major organ involvement (42%) than those with mucocutaneous involvement (35%) and the control groups. There were significantly more BS patients with active major organ involvement who had thought to terminate their lives without plans within the last year (25.5%) compared to those with active mucocutaneous involvement (8.7%) and active AS patients (10%) (p=0.012). Patient-reported joint pain (β=-0.155, p=0.046), BDQoL (β=0.176, p=0.032), and BDI (β=0.017, p<0.0001) scores, suicidal thoughts before the onset of BS (β=-0.124, p=0.043), neurologic involvement (β=0.119, p=0.047) and past prednisone use (β=0.212, p=0.005) were independent predictors of suicidal thoughts.
CONCLUSIONS:
BS patients with major organ involvement have increased thoughts of suicide during the active stages of their disease. A number of risk factors could help physicians to identify patients with increased suicidal thoughts.

Rheumatology Article